| Year |
Citation |
Score |
| 2023 |
Wilk EJ, Howton TC, Fisher JL, Oza VH, Brownlee RT, McPherson KC, Cleary HL, Yoder BK, George JF, Mrug M, Lasseigne BN. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion. Molecular Medicine (Cambridge, Mass.). 29: 67. PMID 37217845 DOI: 10.1186/s10020-023-00664-z |
0.718 |
|
| 2021 |
Libby CJ, Gc S, Benavides GA, Fisher JL, Williford SE, Zhang S, Tran AN, Gordon ER, Jones AB, Tuy K, Flavahan W, Gordillo J, Long A, Cooper SJ, Lasseigne BN, et al. A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1. Cell Adhesion & Migration. 15: 101-115. PMID 33843470 DOI: 10.1080/19336918.2021.1903684 |
0.473 |
|
| 2020 |
Cochran JN, Geier EG, Bonham LW, Newberry JS, Amaral MD, Thompson ML, Lasseigne BN, Karydas AM, Roberson ED, Cooper GM, Rabinovici GD, Miller BL, Myers RM, Yokoyama JS. Non-Coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases. American Journal of Human Genetics. PMID 32330418 DOI: 10.1016/J.Ajhg.2020.03.010 |
0.727 |
|
| 2019 |
Cochran JN, McKinley EC, Cochran M, Amaral MD, Moyers BA, Lasseigne BN, Gray DE, Lawlor JMJ, Prokop JW, Geier EG, Holt JM, Thompson ML, Newberry JS, Yokoyama JS, Worthey EA, et al. Genome sequencing for early-onset or atypical dementia: high diagnostic yield and frequent observation of multiple contributory alleles. Cold Spring Harbor Molecular Case Studies. 5. PMID 31836585 DOI: 10.1101/mcs.a003491 |
0.721 |
|
| 2019 |
Gelfman S, Dugger SA, Araujo Martins Moreno C, Ren Z, Wolock CJ, Shneider N, Phatnani H, Cirulli ET, Lasseigne BN, Harris T, Maniatis T, Rouleau G, Brown RH, Gitler AD, Myers RM, et al. A new approach for rare variation collapsing on functional protein domains implicates specific genic regions in ALS. Genome Research. PMID 30940688 DOI: 10.1101/Gr.243592.118 |
0.649 |
|
| 2019 |
Cochran ME, Cochran JN, McKinley E, Amaral MD, Moyer B, Lasseigne BN, Gray D, Lawlor JM, Prokop J, Newberry JS, Worthey EA, Geldmacher DS, Natelson Love MC, Myers RM, Roberson ED. P3-143: UTILITY OF GENOMIC SEQUENCING IN CASES OF EARLY-ONSET AND FAMILIAL DEMENTIA Alzheimer's & Dementia. 15: P986-P986. DOI: 10.1016/J.Jalz.2019.06.3171 |
0.583 |
|
| 2019 |
Cochran JN, Geier EG, Acosta-Uribe J, Thompson ML, Amaral MD, Newberry JS, Lawlor JMJ, Lasseigne BN, Cochran ME, Bonham LW, Karydas AM, Roberson ED, Lopera F, Kosik KS, Cooper GM, et al. P2-126: Loss-Of-Function Coding And Non-Coding Variants In Tet2 Are Associated With Neurodegenerative Diseases Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2533 |
0.576 |
|
| 2018 |
Lasseigne BN, Brooks JD. The Role of DNA Methylation in Renal Cell Carcinoma. Molecular Diagnosis & Therapy. PMID 29777398 DOI: 10.1007/S40291-018-0337-9 |
0.358 |
|
| 2017 |
Ramaker RC, Bowling KM, Lasseigne BN, Hagenauer MH, Hardigan AA, Davis NS, Gertz J, Cartagena PM, Walsh DM, Vawter MP, Jones EG, Schatzberg AF, Barchas JD, Watson SJ, Bunney BG, et al. Post-mortem molecular profiling of three psychiatric disorders. Genome Medicine. 9: 72. PMID 28754123 DOI: 10.1186/S13073-017-0458-5 |
0.697 |
|
| 2017 |
Ramaker RC, Lasseigne BN, Hardigan AA, Palacio L, Gunther DS, Myers RM, Cooper SJ. RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature. Oncotarget. PMID 28454104 DOI: 10.18632/Oncotarget.16961 |
0.73 |
|
| 2017 |
Kirby MK, Ramaker RC, Roberts BS, Lasseigne BN, Gunther DS, Burwell TC, Davis NS, Gulzar ZG, Absher DM, Cooper SJ, Brooks JD, Myers RM. Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns. Bmc Cancer. 17: 273. PMID 28412973 DOI: 10.1186/S12885-017-3252-2 |
0.709 |
|
| 2017 |
Alonso A, Lasseigne BN, Williams K, Nielsen J, Ramaker RC, Hardigan AA, Johnston B, Roberts BS, Cooper SJ, Marsal S, Myers RM. aRNApipe: A balanced, efficient and distributed pipeline for processing RNA-seq data in high performance computing environments. Bioinformatics (Oxford, England). PMID 28108448 DOI: 10.1093/Bioinformatics/Btx023 |
0.7 |
|
| 2016 |
McDaniel JM, Varley KE, Gertz J, Savic DS, Roberts BS, Bailey SK, Shevde LA, Ramaker RC, Lasseigne BN, Kirby MK, Newberry KM, Partridge EC, Jones AL, Boone B, Levy SE, et al. Genomic regulation of invasion by STAT3 in triple negative breast cancer. Oncotarget. PMID 28030809 DOI: 10.18632/Oncotarget.14153 |
0.723 |
|
| 2016 |
Ghatalia P, Yang ES, Lasseigne BN, Ramaker RC, Cooper SJ, Chen D, Sudarshan S, Wei S, Guru AS, Zhao A, Cooper T, Della Manna DL, Naik G, Myers RM, Sonpavde G. Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets. Plos One. 11: e0160924. PMID 27574806 DOI: 10.1371/Journal.Pone.0160924 |
0.723 |
|
| 2015 |
Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science (New York, N.Y.). 347: 1436-41. PMID 25700176 DOI: 10.1126/Science.Aaa3650 |
0.659 |
|
| 2014 |
Lasseigne BN, Burwell TC, Patil MA, Absher DM, Brooks JD, Myers RM. DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. Bmc Medicine. 12: 235. PMID 25472429 DOI: 10.1186/S12916-014-0235-X |
0.602 |
|
| Show low-probability matches. |